These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32914211)

  • 41. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertonic sodium chloride and mannitol induces COX-2 via different signaling pathways in mouse cortical collecting duct M-1 cells.
    Lim W; Jung J; Surh Y; Inoue H; Lee Y
    Life Sci; 2007 May; 80(22):2085-92. PubMed ID: 17477937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
    Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
    J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pax transactivation-domain interacting protein is required for urine concentration and osmotolerance in collecting duct epithelia.
    Kim D; Wang M; Cai Q; Brooks H; Dressler GR
    J Am Soc Nephrol; 2007 May; 18(5):1458-65. PubMed ID: 17429055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Farnesoid X receptor (FXR) inhibits coagulation process via inducing hepatic antithrombin III expression in mice.
    Luan ZL; Wei YY; Wang YC; Ming WH; Zhang HB; Wang B; Cui XH; Li YY; Guan YF; Zhang XY
    Sheng Li Xue Bao; 2021 Oct; 73(5):795-804. PubMed ID: 34708236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
    Kast HR; Nguyen CM; Sinal CJ; Jones SA; Laffitte BA; Reue K; Gonzalez FJ; Willson TM; Edwards PA
    Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage.
    Gai Z; Chu L; Xu Z; Song X; Sun D; Kullak-Ublick GA
    Sci Rep; 2017 Aug; 7(1):9815. PubMed ID: 28852062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of FXR protects against renal fibrosis via suppressing Smad3 expression.
    Zhao K; He J; Zhang Y; Xu Z; Xiong H; Gong R; Li S; Chen S; He F
    Sci Rep; 2016 Nov; 6():37234. PubMed ID: 27853248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
    Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
    J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silencing and overexpression of the gamma-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stress.
    Capasso JM; Rivard CJ; Berl T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1142-7. PubMed ID: 16804105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
    FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.
    Ramos Pittol JM; Milona A; Morris I; Willemsen ECL; van der Veen SW; Kalkhoven E; van Mil SWC
    Gastroenterology; 2020 Nov; 159(5):1853-1865.e10. PubMed ID: 32712104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.